Literature DB >> 4140512

Alterations of membrane glycopeptides in human colonic adenocarcinoma.

Y S Kim, R Isaacs, J M Perdomo.   

Abstract

Membrane glycopeptides were examined in human colonic adenocarcinoma and normal colonic mucosa. The carbohydrates of membrane glycopeptides were found to be markedly reduced in tumor tissue and the relative proportions of the various sugars were altered. Although all of the sugars were lower in tumor tissue when compared to the adjacent normal mucosa, galactosamine, fucose, and sialic acid were more significantly reduced. Examination of the blood group activity and lectin-binding properties of membrane glycopeptides revealed that specific carbohydrate structures had changed in the tumor tissue. Most striking of these changes was the disappearance of glycoprotein-associated blood group A activity. Assay of the enzyme responsible for synthesis of the blood group A determinant showed that this glycosyltransferase activity was greatly diminished in tumor tissue. A galactosyltransferase and a fucosyltransferase were also significantly lower in the tumor tissue whereas the levels of another galactosyltransferase and a sialyltransferase were unaltered. Glycosidase activities in the normal and tumor tissues were similar. The results show that an alteration in glycoprotein biosynthesis occurred during tumorigenesis that resulted in a modified membrane glycoprotein composition and that these changes are probably a reflection of reduced levels of the enzymes responsible for glycoprotein synthesis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4140512      PMCID: PMC434000          DOI: 10.1073/pnas.71.12.4869

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Absence of a specific ganglioside galactosyltransferase in mouse cells transformed by murine sarcoma virus.

Authors:  P H Fishman; R O Brady; R M Bradley; S A Aaronson; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

2.  Membrane glycopeptides from subcellular fractions of control and virus-transformed cells.

Authors:  C A Buck; J P Fuhrer; G Soslau; L Warren
Journal:  J Biol Chem       Date:  1974-03-10       Impact factor: 5.157

3.  Altered growth behavior of malignant cells associated with changes in externally labeled glycoprotein and glycolipid.

Authors:  C G Gahmberg; S I Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

Review 4.  Surface glycoproteins of cells before and after transformation by oncogenic viruses.

Authors:  L Warren; J P Fuhrer; C A Buck
Journal:  Fed Proc       Date:  1973-01

5.  Transformation of Swiss 3T3 cells by murine sarcoma virus is followed by decrease in a glycolipid glycosyltransferase.

Authors:  P T Mora; P H Fishman; R H Bassin; R O Brady; V W McFarland
Journal:  Nat New Biol       Date:  1973-10-24

6.  Distribution and regulation of deoxythymidine kinase activity in differentiating cells of mammalian intestines.

Authors:  J S Salser; M E Balis
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

7.  Membrane glycoproteins of the rat small intestine. Chemical composition of membrane glycoproteins.

Authors:  Y S Kim; J M Perdomo
Journal:  Biochim Biophys Acta       Date:  1974-03-14

8.  Differential release of sialic acid from normal and malignant cells by Vibrio cholerae neuraminidase or influenza virus neuraminidase.

Authors:  R K Ray; R L Simmons
Journal:  Cancer Res       Date:  1973-05       Impact factor: 12.701

9.  Enzymic conversion of "H1-glycolipid" to A or B-glycolipid and deficiency of these enzyme activities in adenocarcinoma.

Authors:  K Stellner; S Hakomori; G S Warner
Journal:  Biochem Biophys Res Commun       Date:  1973-11-16       Impact factor: 3.575

10.  Mammary carcinoma: enzymatic block in disialoganglioside biosynthesis.

Authors:  T W Keenan; D J Morré
Journal:  Science       Date:  1973-11-20       Impact factor: 47.728

View more
  21 in total

Review 1.  Mucin glycoproteins in neoplasia.

Authors:  Y S Kim; J Gum; I Brockhausen
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

2.  Secretory glycoconjugates of a mucin-synthesizing human colonic adenocarcinoma cell line. Analysis using double labeling with lectins.

Authors:  T E Phillips; E B Frisch
Journal:  Histochemistry       Date:  1990

3.  The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution.

Authors:  B C Wolf; R R Salem; H F Sears; D A Horst; P T Lavin; M Herlyn; S H Itzkowitz; J Schlom; G D Steele
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

4.  Evidence of altered structural and secretory glycoconjugates in the jejunal mucosa of patients with gluten sensitive enteropathy and subtotal villous atrophy.

Authors:  M Vecchi; G Torgano; R de Franchis; S Tronconi; D Agape; G Ronchi
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

Review 5.  [Biology of lectins and their application in clinical biochemistry (author's transl)].

Authors:  E Köttgen
Journal:  Klin Wochenschr       Date:  1977-04-15

6.  [Glycoproteins: their biological and clinical significance. II (author's transl)].

Authors:  E Köttgen; C Bauer; W Reutter; W Gerok
Journal:  Klin Wochenschr       Date:  1979-03-01

Review 7.  Serum sialylation changes in cancer.

Authors:  Zejian Zhang; Manfred Wuhrer; Stephanie Holst
Journal:  Glycoconj J       Date:  2018-04-21       Impact factor: 2.916

Review 8.  Serum-sialyltransferase activity in cancer patients.

Authors:  P G Berge; A Wilhelm; H Schriewer; G Wüst
Journal:  Klin Wochenschr       Date:  1982-05-03

9.  Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation.

Authors:  C R Boland; C K Montgomery; Y S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

10.  Sialyltransferase activity in tumor tissues.

Authors:  P G Berge; A Wilhelm; H Schriewer
Journal:  Klin Wochenschr       Date:  1984-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.